BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 35258800)

  • 1. 6-Hydroxydopamine Induces Neurodegeneration in Terminally Differentiated SH-SY5Y Neuroblastoma Cells via Enrichment of the Nucleosomal Degradation Pathway: a Global Proteomics Approach.
    Magalingam KB; Somanath SD; Ramdas P; Haleagrahara N; Radhakrishnan AK
    J Mol Neurosci; 2022 May; 72(5):1026-1046. PubMed ID: 35258800
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison between proliferative and neuron-like SH-SY5Y cells as an in vitro model for Parkinson disease studies.
    Lopes FM; Schröder R; da Frota ML; Zanotto-Filho A; Müller CB; Pires AS; Meurer RT; Colpo GD; Gelain DP; Kapczinski F; Moreira JC; Fernandes Mda C; Klamt F
    Brain Res; 2010 Jun; 1337():85-94. PubMed ID: 20380819
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.
    Lopes FM; da Motta LL; De Bastiani MA; Pfaffenseller B; Aguiar BW; de Souza LF; Zanatta G; Vargas DM; Schönhofen P; Londero GF; de Medeiros LM; Freire VN; Dafre AL; Castro MA; Parsons RB; Klamt F
    Neurotox Res; 2017 May; 31(4):545-559. PubMed ID: 28155214
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tocotrienols protect differentiated SH-SY5Y human neuroblastoma cells against 6-hydroxydopamine-induced cytotoxicity by ameliorating dopamine biosynthesis and dopamine receptor D2 gene expression.
    Magalingam KB; Somanath SD; Md S; Haleagrahara N; Fu JY; Selvaduray KR; Radhakrishnan AK
    Nutr Res; 2022 Feb; 98():27-40. PubMed ID: 35065349
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anthraquinone from Edible Fungi Pleurotus ostreatus Protects Human SH-SY5Y Neuroblastoma Cells Against 6-Hydroxydopamine-Induced Cell Death-Preclinical Validation of Gene Knockout Possibilities of PARK7, PINK1, and SNCA1 Using CRISPR SpCas9.
    J B; Das A; Sakthivel KM
    Appl Biochem Biotechnol; 2020 Jun; 191(2):555-566. PubMed ID: 31820379
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Synchrotron radiation-based FTIR microspectroscopy study of 6-hydroxydopamine induced Parkinson's disease cell model].
    Zhu HY; Pei X; Wu LY; Qi ZM; Wang YY; Liu B; Zhou HG
    Guang Pu Xue Yu Guang Pu Fen Xi; 2013 Mar; 33(3):686-9. PubMed ID: 23705433
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of cross-tolerance between protective effect of morphine and nicotine in 6-hydroxydopamine-induce neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells.
    Elyasi L; Eftekhar-Vaghefi SH; Asadi-Shekaari M; Esmaeili-Mahani S
    Int J Neurosci; 2019 Feb; 129(2):129-138. PubMed ID: 29947270
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Protective effects of 6,7,4'-trihydroxyisoflavone, a major metabolite of daidzein, on 6-hydroxydopamine-induced neuronal cell death in SH-SY5Y human neuroblastoma cells.
    Ko YH; Kwon SH; Kim SK; Lee BR; Hur KH; Kim YJ; Kim SE; Lee SY; Jang CG
    Arch Pharm Res; 2019 Dec; 42(12):1081-1091. PubMed ID: 31705299
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Involvement of extracellular signal-regulated kinases 1/2 and (phosphoinositide 3-kinase)/Akt signal pathways in acquired resistance against neurotoxin of 6-hydroxydopamine in SH-SY5Y cells following cell-cell interaction with astrocytes.
    Jiang Z; Yu PH
    Neuroscience; 2005; 133(2):405-11. PubMed ID: 15878643
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dihydroisotanshinone I and BMAL-SIRT1 Pathway in an In Vitro 6-OHDA-Induced Model of Parkinson's Disease.
    Su HC; Sun YT; Yang MY; Wu CY; Hsu CM
    Int J Mol Sci; 2023 Jul; 24(13):. PubMed ID: 37446264
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential toxicity of 6-hydroxydopamine in SH-SY5Y human neuroblastoma cells and rat brain mitochondria: protective role of catalase and superoxide dismutase.
    Iglesias-González J; Sánchez-Iglesias S; Méndez-Álvarez E; Rose S; Hikima A; Jenner P; Soto-Otero R
    Neurochem Res; 2012 Oct; 37(10):2150-60. PubMed ID: 22821477
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid Analysis of the 6-Hydroxydopamine-Treated SH-SY5Y Cell Model for Parkinson's Disease.
    Xicoy H; Brouwers JF; Kalnytska O; Wieringa B; Martens GJM
    Mol Neurobiol; 2020 Feb; 57(2):848-859. PubMed ID: 31493240
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citronellol Prevents 6-OHDA-Induced Oxidative Stress, Mitochondrial Dysfunction, and Apoptosis in Parkinson Disease Model of SH-SY5Y Cells via Modulating ROS-NO, MAPK/ERK, and PI3K/Akt Signaling Pathways.
    Shao J; Liu X; Lian M; Mao Y
    Neurotox Res; 2022 Dec; 40(6):2221-2237. PubMed ID: 36097250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protective effect of orexin-A on 6-hydroxydopamine-induced neurotoxicity in SH-SY5Y human dopaminergic neuroblastoma cells.
    Esmaeili-Mahani S; Vazifekhah S; Pasban-Aliabadi H; Abbasnejad M; Sheibani V
    Neurochem Int; 2013 Dec; 63(8):719-25. PubMed ID: 24135219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autophagy-dependent and -independent involvement of AMP-activated protein kinase in 6-hydroxydopamine toxicity to SH-SY5Y neuroblastoma cells.
    Arsikin K; Kravic-Stevovic T; Jovanovic M; Ristic B; Tovilovic G; Zogovic N; Bumbasirevic V; Trajkovic V; Harhaji-Trajkovic L
    Biochim Biophys Acta; 2012 Nov; 1822(11):1826-36. PubMed ID: 22917563
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Studies on Regulation of Global Protein Profile and Cellular Bioenergetics of Differentiating SH-SY5Y Cells.
    Pandey A; Sarkar S; Yadav SK; Yadav SS; Srikrishna S; Siddiqui MH; Parmar D; Yadav S
    Mol Neurobiol; 2022 Mar; 59(3):1799-1818. PubMed ID: 35025051
    [TBL] [Abstract][Full Text] [Related]  

  • 17. p-Hydroxybenzyl Alcohol Antagonized the ROS-Dependent JNK/Jun/Caspase-3 Pathway to Produce Neuroprotection in a Cellular Model of Parkinson's Disease.
    Lai MC; Liu WY; Liou SS; Liu IM
    Nutrients; 2022 Nov; 14(23):. PubMed ID: 36501032
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Schisantherin A protects against 6-OHDA-induced dopaminergic neuron damage in zebrafish and cytotoxicity in SH-SY5Y cells through the ROS/NO and AKT/GSK3β pathways.
    Zhang LQ; Sa F; Chong CM; Wang Y; Zhou ZY; Chang RC; Chan SW; Hoi PM; Yuen Lee SM
    J Ethnopharmacol; 2015 Jul; 170():8-15. PubMed ID: 25934514
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cathepsin X promotes 6-hydroxydopamine-induced apoptosis of PC12 and SH-SY5Y cells.
    Pišlar AH; Zidar N; Kikelj D; Kos J
    Neuropharmacology; 2014 Jul; 82():121-31. PubMed ID: 23958447
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protective Effects of Fisetin Against 6-OHDA-Induced Apoptosis by Activation of PI3K-Akt Signaling in Human Neuroblastoma SH-SY5Y Cells.
    Watanabe R; Kurose T; Morishige Y; Fujimori K
    Neurochem Res; 2018 Feb; 43(2):488-499. PubMed ID: 29204750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.